Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3094 (LINC03094, also known as lnc-SMC2-1) is classified as a **long intergenic non-coding RNA (lincRNA)**, a class of RNA transcripts longer than 200 nucleotides that do not code for proteins and are transcribed from genomic regions between known protein-coding genes[1][3][5][7][9]. LINC03094 is catalogued in multiple gene databases, including NCBI Gene (101928523), Ensembl (ENSG00000285483), and HGNC (56725)[1][3][5][7][9]. It is a member of the lncRNA/lincRNA family, which is increasingly recognized for roles in the regulation of gene expression, modulation of chromatin structure, and interaction with other RNAs and proteins[10]. Though specific functional or disease-related data for LINC03094 itself are not available in major resources, other lincRNAs often participate in biologically significant processes such as cell cycle, apoptosis, and immune response, and have been associated with various human cancers—frequently as regulators rather than direct therapeutic targets[10]. **LINC03094 is not a classical therapeutic target** (such as an enzyme, receptor, or transporter) and there is no reported evidence of interacting drugs or validated use as a biomarker. Its aliases include lnc-SMC2-1, and it appears in multiple transcriptomic databases under different accession numbers and synonyms[1][5][9]. At present, there is no indication of misspelling, incorrect classification, or major ambiguities associated with this gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3094 (LINC03094).